Skip to main content
NCBI home page
Cellular and Molecular Neurobiology logoLink to Cellular and Molecular Neurobiology
. 2004 Jun;24(3):301–316. doi: 10.1023/B:CEMN.0000022764.94760.3f

Cell Transplantation for Parkinson's Disease: Present Status

René Drucker-Colín 1, Leticia Verdugo-Díaz 2
PMCID: PMC11529974  PMID: 15206816

Abstract

1. Parkinson's disease (PD) is a neurodegenerative disorder caused by the loss of neurons in the substantia nigra pars compacta and a striatal deficiency of dopamine. PD typically affects people in late middle age and progresses slowly. In the early stages of the disease, treatment targeting the dopaminergic network is effective. However, with disease progression, transplantation is an option for repairing and replacing missing dopaminergic neurons.

2. In this review, we evaluate the tissue grafts and cellular therapies that have and are being considered. Clinical trials were originally derived from transplants of adrenal medullary chromaffin cells and embryonic nigral dopaminergic neurons in patients with PD.

3. Recently, novel molecular and cellular treatments are being utilized in animals and these include embryonic stem cells, fetal cells from pigs, or transfected cells. In spite of new molecular techniques and some 20 years of experience, the transplantation therapy for PD has today the same problems and results as the first reports which used neural fetal tissue or adrenal grafts.

Keywords: grafts, chromaffin cells, animal models, magnetic fields

REFERENCES

  1. Albin, R. L., Young, A. B., and Penney, J. B. (1989). The functional anatomy of basal ganglia disorders. TINS12(10):366-374. [DOI] [PubMed] [Google Scholar]
  2. Allen, G. S., Burns R. S., and Tullipan, M. B. (1989). Adrenal medulary transplantation to the caudate nucleus in Parkinson's disease. Initial clinical results in 18 patients. Arch. Neurol.46:487-491. [DOI] [PubMed] [Google Scholar]
  3. Backlund, E.-O., Granberg, P.-O., Hamberger, B., Knutson, E., Martensson, A., Sedvall, G., Seiger, A., and Olson, L. (1985). Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials. J. Neurosurg.62:169-173. [DOI] [PubMed] [Google Scholar]
  4. Barker, R. A. (2002). Repairing the brain in Parkinson's disease: Where next? Mov. Disord.17(2):233-241. [DOI] [PubMed] [Google Scholar]
  5. Björklund, L. M., Sánchez-Pernaute, R., Chung, S., Andersson, T., Ching-Chen, I. Y., McNaught, K. P., Brownell, A. L., Jenkins, B. G., Wahlestedt, C., Kim, K. S., and Isacson, O. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. PNAS99(4):2344-2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Björklund, A., and Steveni, U. (1979). Reconstruction of the nigro-striatal dopamine pathway by intra-cerebral nigral transplants. Brain Res.177:555-560. [DOI] [PubMed] [Google Scholar]
  7. Check, E. (2002). Parkinson's patients show positive response to implants. Nature416:666. [DOI] [PubMed] [Google Scholar]
  8. Clarkson, E. D., Zawada, W. M., Adams, F. S., Bell, K. P., and Freed, C. R. (1998). Strands of embryonic mesencephalic tissue show greater dopamine neuron survival and better behavioral improvement than cell suspensions after transplantation in parkinsonian rats. Brain Res.806:60-68. [DOI] [PubMed] [Google Scholar]
  9. Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M. (1967). Aromatic amino acids and modification of Parkinsonism. N. Engl. J. Med.276:374-379. [DOI] [PubMed] [Google Scholar]
  10. Crawford, G. D.Jr., Le, W. D., Smith, R. G., Xie, W. J., Stefani, E., and Appel, S. H. (1992). A novel N18TG2 x mesencephalon cell hybrid expresses properties that suggest a dopaminergic cell line of substantia nigra origin. J. Neurosci.12:3392-3398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Date, I., Imaoka, T., Myshohi, Y., Ono, T., Asar, S., and Ohmoto, T. (1996). Chromaffin cell survival and host dopaminergic fiber recovery in a patient with Parkinson's disease treated by cografts of adrenal medulla and pretransected peripheral nerve. Case report. J. Neurosurg. 84(4):685-689. [DOI] [PubMed] [Google Scholar]
  12. Date, I., and Ohmoto, T. (1996). Neural transplantation and trophic factors in Parkinson's disease: Special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting. Exp. Neurol.137(2):333-344. [DOI] [PubMed] [Google Scholar]
  13. Deacon, T., Schumacher, J., Dinsmore, J., Thomas, C., Palmer, P., Kott, S., Edge, A., Penney, D., Kassissieh, S., Dempsey, P., and Isacson, O. (1997). Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nat. Med.3(3):350-353. [DOI] [PubMed] [Google Scholar]
  14. Del Conte, G. (1907). Einpflanzungen von embryonalem Gewebe ins Gehirn. Beitr. Pathol. Anat.42:193-201. [Google Scholar]
  15. Drucker-Colín, R., Aguilar-Roblero, R., García-Hernández, F., Fernández Cancino, F., and Bermúdez-Rattoni, F. (1984). Fetal suprachiasmatic nucleus transplants: Diurnal rhythm recovery of lesioned rats. Brain Res.311:353-357. [DOI] [PubMed] [Google Scholar]
  16. Drucker-Colín, R., Madrazo, I., Ostrosky-Solís, F., Shkurovich, M., Franco, R., and Torres, C. (1988). Adrenal medullary tissue transplants in the caudate nucleus of Parkinson's patients. Prog. Brain Res.78:567-574. [DOI] [PubMed] [Google Scholar]
  17. Drucker-Colín, R., Verdugo-Díaz, L., Méndez, M., Carrillo-Ruiz, J., Morgado-Valle, C., Hernández-Cruz, A., and Corkidi, G. (1994). Comparison between low frequency magnetic (LFM) field stimulation and nerve growth factor (NGF) treatment of cultured chromaffin cells, on neurite growth, noradrenaline release, excitable properties and grafting in nigro-striatal lesioned rats. Mol. Cell. Neurosci.5:485-498. [DOI] [PubMed] [Google Scholar]
  18. Drucker-Colín, R., Verdugo-Díaz, L., Morgado-Valle, C., Solís-Maldonado, G., Ondarza, R., Boll, C., Miranda, G., Wang, G. J., and Volkow, N. (1999). Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson's disease patient: A preliminary report. Arch. Med. Res.30:33-39. [DOI] [PubMed] [Google Scholar]
  19. Dunn, E. H. (1917). Primary and secondary findings in a series of attempts to transplant cerebral cortex in the albino rat. J. Comp. Neurol.27:565-582. [Google Scholar]
  20. Fahn, S. (1986). Parkinson's disease and other basal ganglion disorders. In Asbury, A. K., McKlann, G. M., and McDonald, W. I. (eds.), Clinical Neurobiology, London. Saunders, pp. 1217-1228. [Google Scholar]
  21. Feria-Velasco, A., Castillo-Medina, S., Verdugo-Díaz, L., Castellanos, E., Orozco-Suárez, S., Sánchez-Gómez, C., and Drucker-Colín, R. (1998). Neuronal differentiation of chromaffin cells in vitro, induced by extremely low frequency magnetic fields or nerve growth factor: An histological and ultrastructural comparative study. J. Neurosci. Res.53:569-582. [DOI] [PubMed] [Google Scholar]
  22. Fine, A., Hunt, S. P., Oertel, W. H., Nomoto, M., Chuong, P. N., Bond, A., Waters, C., Temlett, J. A., Annett, L., Dunnett, S., Jenner, P., and Marsden, C. D. (1988). Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine. In Gash, D. M., and Sladek, J. R., Jr. (eds.), Transplantation in the Mammalian CNS, Elsevier, Amsterdam, pp. 479-489. [DOI] [PubMed] [Google Scholar]
  23. Fisher, L. J., and Gage, F. H. (1993). Grafting in the mammalian central nervous system. Physiol. Rev.73(3):583-616. [DOI] [PubMed] [Google Scholar]
  24. Flerko, B., and Szentagothai, J. (1957). Oestrogen sensitive neurvous structures in the hypothalamus. Acta Endocrinol (Cpenh). 26(2):121-127. [DOI] [PubMed] [Google Scholar]
  25. Freed, C. R., Breeze, R. E., and Rosenberg, N. L. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12-46 months after transplantation for Parkinson's disease. N. Engl J. Med.327:1549-1555. [DOI] [PubMed] [Google Scholar]
  26. Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Wells, T. H., Barret, J. N., Grafton, S. T., Huang, S. C., Eidelberg, D., and Rottenberg, D. A. (1990). Transplantation of human fetal dopamine cells for Parkinson's disease: Results at 1 year. Arch. Neurol.47:505-512. [DOI] [PubMed] [Google Scholar]
  27. Freed, C. R., Greene, P. E., Breeze, R. E., Tsai, W. Y., DuMouchel, W., Kao, R., Dillon, S., Winfield, H., Culver, S., Trojanowski, J. W., Eidelberg, D., and Fahn, S. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med.344:710-719. [DOI] [PubMed] [Google Scholar]
  28. Freed, W. J., Morishisa, S. M., Spoo E., Hoffer, B. J., Olson, L., Seiger, A., and Wyatt, R. J. (1981). Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature292(5821):351-352. [DOI] [PubMed] [Google Scholar]
  29. Goetz, C. G. (1992). Adrenal medulla. Clin. Restor. Neurol. Neurosci.4:194. [Google Scholar]
  30. Goetz, C. G., Olanow, C. W., Koller, W. C., Penn, R. D., Cahill, D., Morantz, R., Stebbins, G., Tanner, C. M., Klawans, H. L., Shannon, K. M., Comella, C. L., Witt, T., Cox, C., Wasman, M., and Cauger, L. (1989). Multicenter study of autologous adrenal medullary transplantation of the corpus striatum in patients with advanced Parkinson's disease. N. Engl. J. Med.320:337-341. [DOI] [PubMed] [Google Scholar]
  31. Halász, B., Popp, L., Vhlarik, S., and Tima, L. (1965). Further studies on the hormone secretion of the anterior pituitary transplanted into the hypophysiotrophic area of the rat hypothalamus. Endocrinology77(2):343-355. [DOI] [PubMed] [Google Scholar]
  32. Hefti, F., Hartikka, J., and Schlumpf, M. (1985). Implantation of PC12 cells into the corpus striatum of rats with lesions of the dopaminergic nigrostriatal neurons. Brain Res.348:283-288. [DOI] [PubMed] [Google Scholar]
  33. Hitchcock, E. R., Kenny, B. G., Clough, C. G., Hughes, R. C., Henderson, B. T., and Detta, A. (1990). Stereotactic implantation of fetal neosencephalon. Stereotact. Funct. Neurosurg.54:282-289. [DOI] [PubMed] [Google Scholar]
  34. Holden, C. (2002). Versatile cells against intractable diseases. Science297:500-502. [DOI] [PubMed] [Google Scholar]
  35. Hurtig, H., Joyce, J., Sladek, J. R., and Trojanowski, J. Q. (1989). Postmortem analysis of adrenal-medulla-to-caudate autograft in a patient with Parkinson's disease. J. Neurol.25:607-614. [DOI] [PubMed] [Google Scholar]
  36. Isacson, O. (2002). Models of repair mechanisms for future treatment modalities of Parkinson's disease. Brain Res. Bull.57(6):839-846. [DOI] [PubMed] [Google Scholar]
  37. Itakura, T., Uematsu, Y., Nakao, N., Nakai, E., and Nakai, K. (1997). Transplantation of autologous sympathetic ganglion into the brain with Parkinson's disease. Long-term follow-up of 35 cases. Stereotact. Funct. Neurosurg.69:112-115. [DOI] [PubMed] [Google Scholar]
  38. Jenner, P. N. (1992). Paroxetine: An overview of dosage, tolerability and safety. Int. Clin Psychopharmacol.4:69-80. [PubMed] [Google Scholar]
  39. Kelly, P. J., Ahlskog, J. E., Van Heerden, J. A., Carmichael, S. L., Stoddard, S. I., and Bell, G. N. (1989). Adrenal medullary autograft transplantation into the striatum of patients with Parkinson's disease. Mayo Clin. Proc.64:282-290. [DOI] [PubMed] [Google Scholar]
  40. Kolarik, J., Nadvornik, P., Dvorak, M., and Andrs, M. (1988). Crossed transvertebral puncture to block spinal ganglion in treatment of pain. Zentralbl. Neurochir.49:185-188. [PubMed] [Google Scholar]
  41. Kordower, J. H., Cochran, E., Penn, R. D., and Goetz, C. G. (1991). Putative chromaffin cell survival and enhanced host-derived TH-fiber innervation following a functional adrenal medulla autograft for Parkinson's disease. Ann. Neurol.29:405-412. [DOI] [PubMed] [Google Scholar]
  42. Koutouzis, T. K., Emerich, D. F., Borlongan, C. V., Freeman, T. B., Cahill, D. W., and Sanberg, P. R. (1994). Cell transplantation for central nervous system disorders. Crit. Rev. Neurobiol.8:125-162. [PubMed] [Google Scholar]
  43. Langston, J. W., Irwin, I., and Ricaurte, G. A. (1987). Neurotoxins, Parkinsonism and Parkinson's disease. Pharmacol. Ther.32(1): 19-49. [DOI] [PubMed] [Google Scholar]
  44. Lawrence, M. S., Ho, D. Y., Sun G. H., Steinberg, G. K., and Sapolsky, R. M. (1996). Overexpression of Bcl-2 with herpes simplex virus vectors protects CNS neurons against neurological insults in vitro and in vivo. J. Neurosci.16:486-496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Le Gross Clark, W. E. (1940). Neuronal differentiation in implanted foetal cortical tissue. J. Neurol. Psychiatry (Lond.)3:263-272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Levivier, M., Przedborski, S., Bencsics, C., and Kang, U. J. (1995). Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neuosci.15:7810-7820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lindvall, O. (1989). Transplantation into the human brain: Present status and future possibilities. J. Neurol. Neurosurg. Psychiatry (Suppl.): 39-54. [DOI] [PMC free article] [PubMed]
  48. Lindvall, O., Backlund, E. O., and Farde, L. (1987). Transplantation in Parkinson's disease: Two cases of adrenal medullary autografts to the putamen. Ann. Neurol.22:457-468. [DOI] [PubMed] [Google Scholar]
  49. Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. I., Sawle, G., Rothwell, J. C., Marsden, C. D., and Björklund, A. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science247:574-577. [DOI] [PubMed] [Google Scholar]
  50. López-Lozano, J. J., Bravo, G., and Abascal, J. (1991). The CPH Neural Transplantation Group grafting of perfused adrenal medullary tissue into the caudate nucleus of patients with Parkinson's disease. J. Neurosurg.75:234-243. [DOI] [PubMed] [Google Scholar]
  51. López-Lozano, J. J., Bravo, G., Abascal, J., Brera, B., Santos, H., and Gómez-Angulo, C. (1992). The CPH Neural Transplantation Group. Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's disease. Lancet339:430. [DOI] [PubMed] [Google Scholar]
  52. López-Lozano, J. J., Bravo, G., Brera, B., Millan, I., Dargallo, J., Salmean, J., Uria, J., and Insausti, J. (1997). Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-Year follow up in 10 patients. J. Neurosurg.86(6):931-942. [DOI] [PubMed] [Google Scholar]
  53. López-Lozano, J. J., Mata, M., and Bravo, G. (2000). Neural transplants in Parkinson disease: Clinical results of 10 years of experience. Group of Neural Transplants of the CPH. Rev. Neurol.30:1077-1083. [PubMed] [Google Scholar]
  54. Madrazo, I., Drucker-Colín, R., Díaz, V., Martínez-Mata, J., Torres, C., and Becerril, J. J. (1987). Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med.316:831-834. [DOI] [PubMed] [Google Scholar]
  55. Madrazo, I., Franco-Bourland, R., and Ostrosky-Solis, F. (1990). Neural transplantation (autoadrenal, fetal nigral and fetal adrenal) in Parkinson's disease: The Mexican experience. Prog. Brain Res.82:593-602. [DOI] [PubMed] [Google Scholar]
  56. Mendoza-Ramírez, J. L., Aguilar-Roblero, R., Zainos-Rosales, A., and Drucker-Colín, R. (1991). Fetal substantia nigra and adrenal medullary grafts placed contralateral to the nigrostriatal lesion side induce a decrease in turning behavior but not in dopamine receptor density. Restor. Neurol. Neurosci.3:277-285. [DOI] [PubMed] [Google Scholar]
  57. Molina, H., Quinones, A. L., and Ortega, I. (1992). Stereotactic transplantation of foetal ventral mesencephalic cells: Cuban experiences from five patients with idiopathic Parkinson's disease. J. Neural Transplant. Plast.3:338-339. [Google Scholar]
  58. Morgado-Valle, C., Verdugo-Díaz, L., García, D. E., Morales-Orozco, Ch., and Drucker-Colín, R. (1998). The role of voltage-gated Ca2 channels in neurite growth of cultured chromaffin cells induced by extremely low frequency (ELF) magnetic field stimulation. Cell Tissue Res.291:217-230. [DOI] [PubMed] [Google Scholar]
  59. Nikkhah, G. (2001). Neural transplantation therapy for Parkinson's disease: Potential and pitfalls. Brain Res. Bull.56(6):509. [DOI] [PubMed] [Google Scholar]
  60. Olanow, C. W., Korkower, J. H., and Freeman, T. B. (1996). Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci.19(3):102-109. [DOI] [PubMed] [Google Scholar]
  61. Olson, L., Backlund, E. O., Ebendal, T., Freedman, R., Hamberger, B., Hansson, P., Hoffer, B. J., Lindbloom, U., Myerson, B., Stromberg, I., Sydow, O., and Seiger, A (1991). Intraputamenal infusion of nerve growth factor to support adrenal medullary autografts in Parkinson's disease. One-year follow-up of first clinical trial. Arch. Neurol.48:373-381. [DOI] [PubMed] [Google Scholar]
  62. Oyesiku, N. M., and Bakay, R. A. (1993). Central nervous system transplantation. In Crockard, A., Hayward, R., and Hoff, J. T. (eds.), Neurosurgery: The Scientific Basis of Clinical Practice, Blackwell Scientific, London, pp. 448-469. [Google Scholar]
  63. Pallini, R., Fernández, E-., Lauretti, L., Dell' Anna, E., La Marca, F., Gangitano, C., DelFa, A., Olivieri-Sangiacomo, C., Sbriccoli, A., and Rossi, G. F. (1996). Superior cervical ganglion regenerating axons through peripheral nerve grafts and reversal of behavioral deficits in hemiparkinsonian rats. J. Neurosurg.84(3):487-493. [DOI] [PubMed] [Google Scholar]
  64. Penn, R. D., Goetz, C. G., Tanner, C. M., Klawans, H. L., Shannn, K. M., Comella, C. L., and Witt, T. R. (1988). The adrenal medullary transplant operation for Parkinson's disease: Clinical observations in five patients. Neurosurgery22:999-1004. [DOI] [PubMed] [Google Scholar]
  65. Perlow, M., Freed, W. J., Hoffer, B., Seiger, A., Olson, L., and Wyatt, R. J. (1979). Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science204:643-647. [DOI] [PubMed] [Google Scholar]
  66. Perlow, M. J., Kokoris, G., Gibson, M. J., Silverman, A. J., Kreiger, D. T., and Zimmerman, E. A. (1987). Accessory olfactory bulb transplants correct hypogonadism in mutant mice. Brain Res.415:158-162. [DOI] [PubMed] [Google Scholar]
  67. Peterson, D. I., Price M. L., and Small, C. S. (1989). Autopsy findings in a patient who had an adrenal-to-brain transplant for Parkinson's disease. Neurology39:235-238. [DOI] [PubMed] [Google Scholar]
  68. Poltorak, M., Isono, M., Freed, W. J., Ronnett G. V., and Snyder, S. H. (1992). Human cortical neuronal cell line (HCN-1): Further in vitro characterization and suitability for brain transplantations. Cell Transplant.1:3-15. [DOI] [PubMed] [Google Scholar]
  69. Ranson, S. W. (1909). Transplantation of the spinal ganglion into the brain. Q. Bull. Northwest. Univ. Med. Sch.11:176-178. [Google Scholar]
  70. Sanberg, P. R., Barlongon, C. V., Othberg, A. L., Saporta, S., Freeman, T. B., and Cameron, D. F. (1997). Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med.3(10): 1129-1132. [DOI] [PubMed] [Google Scholar]
  71. Sanberg, P. R., and Norman, A. B. (1988). Adrenal transplants for Huntington's disease? Nature335:122. [DOI] [PubMed] [Google Scholar]
  72. Sawle, G. V., Bloomfield, P. M., Bjorklund, A., Brooks, D. J., Brundin, P., Leenders, K. L., Lindvall, O., Marsden, C. D., Rehnerona, S., Widner, H., and Frackowiak, R. S. J. (1992). Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann. Neurol.31:166-173. [DOI] [PubMed] [Google Scholar]
  73. Seiger, A., and Olson, L. (1997). Quantification of fiber outgrowth in transplanted central monoamine neurons. Cell Tissue Res.179:285-316. [DOI] [PubMed] [Google Scholar]
  74. Shirai, Y. (1921). On the transplantation of rat sarcoma in adult heterogeneous animals. Jpn. Med. World1:14-15. [Google Scholar]
  75. Sladek, J. R.Jr., and Collier, T. J. (1988). Fetal dopamine neural grafts: Extended reversal of methylphenyltetrahydropine-induced Parkinsonism in monkeys. Prog. Brain Res.78:497-506. [DOI] [PubMed] [Google Scholar]
  76. Tello, J. F. (1911). La influencia del neurotropismo en la regeneración de los centros nerviosos. Trab. Lab. Invest. Biol.9:123-160. [Google Scholar]
  77. Thompson, W. G. (1890). Successsful brain grafting. N.Y. Med. J.51:701-702. [Google Scholar]
  78. Tresco, P. A., Winn, S. R., Tan, S., Jaeger, C. B., Greene, L. A., and Aebischer, P. (1992). Polymer-encapsulated PC12 cells: Long-term survival and associated reduction in lesion-induced rotational behavior. Cell Transplant.1:255-264. [DOI] [PubMed] [Google Scholar]
  79. Ungeistedt U., and Arbuthnott, G. W. (1970). Quantitative recording of rotational benavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res.18(24):485-493. [DOI] [PubMed] [Google Scholar]
  80. Verdugo-Díaz, L., Palomero-Rivero, M., and Drucker-Colín, R. (1998). Differentiation of chromaffin cells by extremely low frequency magnetic field changes ratios of catecholamine type messenger. Bioelectrochem. Bioenerg.46:297-300. [Google Scholar]
  81. Wang, H., and Sagen, J. (1994). Optimization of adrenal medullary allograft conditions for pain alleviation. J. Neural Transplant. Plast.5:49-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Zainos-Rosales, A., Aguilar-Roblero, R., Mendoza-Ramírez, J. L., and Drucker-Colín, R. (1993). 2-Deoxyglucose autoradiographic evidence that substantia nigra grafts in 6-hydroxydopamine lesioned animals produce recovery of motor asymmetries by exerting contralateral effects. Neurosci. Lett.156:99-10. [DOI] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Neurobiology are provided here courtesy of Springer

RESOURCES